Publication Name	World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID	26166
Country	Türkiye

Received	2016-03-29 10:22
Peer-Review Started	2016-04-04 17:57
To Make the First Decision	2016-05-23 10:03
Return for Revision	2016-05-25 19:43
Revised	2016-07-18 02:47
Second Decision	2016-09-12 09:55
Accepted by Journal Editor-in-Chief	2016-09-12 23:10
Accepted by Company Editor-in-Chief	2016-09-22 14:03
Articles in Press	2016-09-22 14:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-10-24 14:26
Publish the Manuscript Online	2016-10-31 09:01

ISSN	2150-5349 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Treatment of pregnant women with a diagnosis of inflammatory bowel disease
Manuscript Source	Invited Manuscript
All Author List	Sule Poturoglu, Asli Ciftcibasi Ormeci and Ali Erkan Duman
Funding Agency and Grant Number
Corresponding Author	Sule Poturoglu, MD, Department of Gastroenterology, Haseki Training and Research Hospital, 34096 Istanbul, Turkey. sulepot@mynet.com
Key Words	Pregnancy; Inflammatory bowel disease; Immunomodulators; Biologics; Breastfeeding; Treatment
Core Tip	Active disease prior to conception and during pregnancy increases the rate of pregnancy-related complications; thus, special attention should be given to pregnancy during the disease remission period. The safest drugs for use during pregnancy and breastfeeding are 5-aminosalicylic acid complexes, thiopurines and corticosteroids. Methotrexate and thalidomide are contraindicated. Anti-tumor necrosis factor treatment should be avoided during the third trimester. The risk of venous thromboembolism is increased in patients with moderate-to-severe disease. The delivery method should be selected according to the region of the body involved and disease activity. In this article, the problems encountered by patients with inflammatory bowel disease from pregnancy to breastfeeding are discussed, and appropriate management strategies are suggested.
Publish Date	2016-10-31 09:01
Citation	Poturoglu S, Ormeci AC, Duman AE. Treatment of pregnant women with a diagnosis of inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2016; 7(4): 490-502
URL	http://www.wjgnet.com/2150-5349/full/v7/i4/490.htm
DOI	http://dx.doi.org/10.4292/wjgpt.v7.i4.490

Full Article (PDF)	WJGPT-7-490.pdf
Full Article (Word)	WJGPT-7-490.doc
Manuscript File	26166-Review.doc
Answering Reviewers	26166-Answering reviewers.pdf
Audio Core Tip	26166-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	26166-Conflict-of-interest statement.pdf
Copyright License Agreement	26166-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	26166-Language certificate.pdf
Peer-review Report	26166-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	26166-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	26166-Scientific misconduct check.pdf
Scientific Editor Work List	26166-Scientific editor work list.pdf